Pharmaceuticals, Biotechnology and Life Sciences
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) — Orphai Therapeutics Inc. (“Orphai”), a clinical-stage biopharmaceutical company dedicated to advancing…
Company implements next growth stage following successful strategic and operational developmentUwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed…
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung…
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment…
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and…
Full-year 2025 revenue reached €1,465m : +7.9% at constant exchange rate and scope (CERS) vs 2024+4.8% at actual rates impacted…
WALTHAM, Mass., Jan. 19, 2026 (GLOBE NEWSWIRE) — BVI, a global leader in the ophthalmic device market, announced today the…
TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”),…
KUALA LUMPUR, Malaysia, Jan. 19, 2026 (GLOBE NEWSWIRE) — CUKTECH has officially announced the launch of its flagship product, the…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…